Add BrightSurf on Google Email

University of California - Los Angeles Health Sciences


Study shows federal safety metric inappropriately penalizes hospitals for lifesaving stroke procedures

A new UCLA study finds that the Patient Safety Indicator 04 (PSI 04) metric is fundamentally flawed when applied to emergency stroke care. The researchers argue that the metric incorrectly flags unavoidable complications of severe strokes, rather than problems with the procedure itself.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of NeuroInterventional Surgery·TypeData/statistical analysis·DateJan 8, 2026

The key to increasing patients’ advance care medical planning may be automatic patient outreach

Research finds that automatic patient outreach significantly increased the number of patients who completed advance care planning documentation. The study, published in Annals of Internal Medicine, suggests that health systems can implement automated mechanisms to promote advance care planning conversations and improve patient outcomes.

SourceUniversity of California - Los Angeles Health Sciences·JournalAnnals of Internal Medicine·TypeRandomized controlled/clinical trial·DateDec 11, 2025

Researchers develop AI Tool to identify undiagnosed Alzheimer's cases while reducing disparities

Researchers developed an AI tool to identify patients with undiagnosed Alzheimer's disease using electronic health records, addressing underdiagnosis and healthcare inequities. The model achieved sensitivity rates of 77-81% across diverse populations, promoting fairness while maintaining high accuracy.

Older age, chronic kidney disease and cerebrovascular disease linked with increased risk for paralysis and death after West Nile virus infection

A study published in JAMA Network Open found that older adults with chronic kidney disease or cerebrovascular disease are at double the risk for developing neuroinvasive West Nile virus infection, which can lead to paralysis and death. The study identified several risk factors, including male sex, immune suppressants, and multiple scle...

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Network Open·TypeData/statistical analysis·DateDec 10, 2025

Researchers develop a new computational tool to understand how genetic interactions impact human traits

A new study developed a powerful computational method, FAME, to detect and quantify genetic interactions. The researchers found 16 instances of interactions on traits such as cholesterol and liver enzymes, which were larger than the effects identified by examining individual variants alone.

SourceUniversity of California - Los Angeles Health Sciences·JournalNature Genetics·TypeObservational study·DateDec 9, 2025

SABCS: Advances in emerging blood-based surveillance tools, new approaches to predicting treatment response and tailoring therapies across the disease spectrum for patients with breast cancer

Researchers at UCLA present several new studies on emerging blood-based surveillance tools, new approaches to predicting treatment response, and tailoring therapies across the disease spectrum for patients with breast cancer. The findings highlight the potential of precision medicine in improving quality of life.

Marriage, emotional support may protect against obesity through brain-gut connection, study finds

A new study published in Gut Microbes reveals that married individuals with higher perceived emotional support have a lower body mass index and fewer food addiction behaviors. The study found that oxytocin pathways linking the brain, gut microbiome, and eating behaviors play a crucial role in shaping obesity risk.

Mental health conditions may heighten liver cancer risk in veterans due to increased hepatitis C, UCLA study finds

A recent study by UCLA Health investigators found that mental health conditions significantly raise the likelihood of developing liver cancer among US veterans living with cirrhosis and hepatitis C. The study suggests that these disorders limit access to hepatitis C care, reducing the chance of a cure.

SourceUniversity of California - Los Angeles Health Sciences·JournalClinical Gastroenterology and Hepatology·DateDec 3, 2025

Veterans with cardiometabolic conditions face significant risk of dying during extreme heat events

A study published in JAMA Network Open finds that veterans with cardiometabolic conditions such as diabetes and high blood pressure are at a 10-14% higher risk of dying during days with extreme heat compared to other days. The researchers also found that homeless veterans faced a 25% higher risk of death vs. housed veterans.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Network Open·TypeData/statistical analysis·DateNov 25, 2025

Colorectal cancer screenings remain low for people ages 45 to 49 despite guideline change

Researchers found that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the USPSTF lowered the recommended screening age to 45. Despite investigating unmet social needs, no significant differences were found in testing uptake for this early midlife cohort.

SourceUniversity of California - Los Angeles Health Sciences·JournalJNCI Journal of the National Cancer Institute·TypeData/statistical analysis·DateNov 18, 2025

UCLA’s Dr. Mina Sedrak receives international award for driving advancements in cancer and aging research

Dr. Sedrak receives King Hussein Cancer Research Award for innovative work on accelerated aging in cancer survivors, with a focus on developing new strategies to prevent or reverse age-related effects. His research aims to improve health span and quality of life for cancer patients, holding promise for other age-related diseases.

Researchers pose five guiding questions to improve the use of artificial intelligence in physicians’ clinical decision-making

A research team provides a framework to support doctors in their patient care while ensuring AI doesn't undermine their expertise. The framework addresses key issues like timing, trust, and over-reliance on AI.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of the American Medical Informatics Association·TypeCommentary/editorial·DateOct 29, 2025

Missing nutrient in breast milk may explain health challenges in children of women with HIV

A new UCLA study reveals that breast milk from women living with HIV contains significantly lower levels of tryptophan, an essential amino acid important for infant immune function and brain development. The study suggests that this depletion may be a common denominator explaining the immune, growth, and cognitive differences seen in c...

SourceUniversity of California - Los Angeles Health Sciences·JournalNature Communications·TypeObservational study·DateOct 28, 2025

Adding chemotherapy to radiation causes greater short-term decline in quality of life for patients with cervical cancer

A new study found that adding chemotherapy to radiation therapy causes a greater decline in quality of life for women with early-stage cervical cancer. The trial measured patient-reported outcomes, including symptoms and side effects, highlighting the need for supportive care during treatment.

Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer

Researchers found that combining zanzalintinib, a targeted therapy drug, with atezolizumab, an immune checkpoint inhibitor, improved survival rates by 20% compared to standard treatment regorafenib. The new combination also delayed cancer progression and showed promising results in patients with metastatic colorectal cancer.

ESMO: 10-year survival data for lung cancer immunotherapy, new PSMA-targeted therapy for recurrent prostate cancer, promising results in metastatic colorectal and urothelial cancers

UCLA investigators unveil decade-long survival data for immunotherapy in advanced lung cancer and promising results for novel therapies targeting PSMA, DKK1, and FGFR3 in various aggressive cancers. These breakthroughs hold promise for improved treatment outcomes and quality of life for patients with difficult-to-treat diseases.

Why women's brains face higher risk: scientists pinpoint X-chromosome gene behind MS and Alzheimer's

Researchers at UCLA Health have identified a sex-chromosome linked gene that drives inflammation in the female brain, making women more susceptible to conditions like Alzheimer's disease and multiple sclerosis. Deactivating this gene and using diabetes medication metformin showed promising results in reducing symptoms in female mice.

SourceUniversity of California - Los Angeles Health Sciences·JournalScience Translational Medicine·DateOct 15, 2025

Child neurologists can play a critical role in identifying movement issues in autism, but more training is needed

A new study found that child neurologists often lack knowledge and education on motor difficulties in children with autism. Motor impairments are common in autistic children, affecting their development, language skills, and social interactions. The study recommends more training for medical students and residents to recognize and addr...

SourceUniversity of California - Los Angeles Health Sciences·JournalPediatric Neurology·TypeSurvey·DateOct 13, 2025

Caregivers identify key barriers to youth enrichment programs in low-income communities

Research finds primary caregivers in urban under-resourced communities highlight the importance of parent input to boost equitable access to out-of-school-time activities. Key strategies include broad outreach, structural investments, and family engagement to improve participation and quality., The study suggests that enrichment and re...

SourceUniversity of California - Los Angeles Health Sciences·JournalMaternal and Child Health Journal·TypeSurvey·DateOct 9, 2025

Scientists create radiotheranostic approach designed to combat aggressive cancers

Researchers create novel antibody-based treatment that combines diagnostic and therapeutic capabilities to target LRRC15-expressing tumors, slowing growth and extending survival. The approach shows promise in preclinical models by priming tumors for immune response and boosting immunotherapy's effectiveness.

SourceUniversity of California - Los Angeles Health Sciences·JournalSignal Transduction and Targeted Therapy·DateOct 8, 2025